Effect of donor-recipient cytomegalovirus serologic status on outcomes in simultaneous kidney-pancreas transplant recipients.
暂无分享,去创建一个
R. Stratta | R. Alloway | A. Lo | E. Hodge | R. Alloway | E. Hodge
[1] R. Stratta,et al. Two-dose daclizumab regimen in simultaneous kidney-pancreas transplant recipients: primary endpoint analysis of a multicenter, randomized study1 , 2003, Transplantation.
[2] R. Stratta,et al. Patterns of cytomegalovirus infection in simultaneous kidney–pancreas transplant recipients receiving tacrolimus, mycophenolate mofetil, and prednisone with ganciclovir prophylaxis , 2001, Transplant infectious disease : an official journal of the Transplantation Society.
[3] R. Rubin,et al. Infection in organ-transplant recipients. , 1998, The New England journal of medicine.